Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
crenezumab
Biotech
Roche Alzheimer's fail has industry circling the wagons
Another failure of an amyloid drug for Alzheimer’s has companies, analysts and patient groups circling the wagons to defend the future of research.
Annalee Armstrong
,
James Waldron
,
Max Bayer
Nov 15, 2022 11:02am
Genentech tries again on diversity aim for Alzheimer's program
Aug 8, 2022 10:10am
Genentech, AC Immune reveal more about crenezumab failure
Aug 2, 2022 11:00am
Will we ever land the Alzheimer's moonshot?
Jun 17, 2022 5:00am
Roche's attack on presymptomatic Alzheimer's ends in failure
Jun 16, 2022 5:04am